Occupational exposure to non-ionizing radiation and an association with heart disease: An exploratory study

Complex chromosome aberrations persist i

Complex chromosome aberrations persist in individuals many years after occupational exposure to densely ionizing radiation: An mFISH study

✍ M. Prakash Hande; Tamara V. Azizova; Ludmilla E. Burak; Valentin F. Khokhryakov; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB

## Abstract Long‐lived, sensitive, and specific biomarkers of particular mutagenic agents are much sought after and potentially have broad applications in the fields of cancer biology, epidemiology, and prevention. Many clastogens induce a spectrum of chromosome aberrations, and some of them can be

Case conferences between general practit

Case conferences between general practitioners and specialist teams to plan end of life care of people with end stage heart failure and lung disease: an exploratory pilot study

✍ Mitchell, Geoffrey; Zhang, Jianzhen; Burridge, Letitia; Senior, Hugh; Miller, El 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 188 KB

Abatacept or tocilizumab after rituximab

Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy

✍ Das, Sudipto (author);Vital, Edward M. (author);Horton, Sarah (author);Bryer, Do 📂 Article 📅 2014 🏛 BMJ Publishing Group 🌐 English ⚖ 253 KB

Abatacept or tocilizumab after rituximab

Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy

✍ Das, Sudipto (author);Vital, Edward M. (author);Horton, Sarah (author);Bryer, Do 📂 Article 📅 2014 🏛 BMJ Publishing Group 🌐 English ⚖ 253 KB

Abatacept or tocilizumab after rituximab

Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy

✍ Das, Sudipto (author);Vital, Edward M. (author);Horton, Sarah (author);Bryer, Do 📂 Article 📅 2014 🏛 BMJ Publishing Group 🌐 English ⚖ 253 KB

Phase I study to determine MTD of doceta

Phase I study to determine MTD of docetaxel and cisplatin with concurrent radiation therapy for stage III non-small cell lung cancer

✍ You-quan Li; An-hui Shi; Fu-hai Li; Rong Yu; Guang-ying Zhu 📂 Article 📅 2011 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 231 KB